FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor
April 15, 2015 at 17:15 PM EDT
The Medicines Company (NASDAQ: MDCO) announced today that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs ...
